Developing both prophylactic 
and therapeutic effective 
countermeasures

Crimean Congo Haemorrhagic Fever 
Vaccine & Immunotherapy

The CCHFVACIM project aims to address the serious public health threat posed by Crimean Congo Haemorrhagic Fever Virus (CCHFV), a tick-borne zoonotic virus that causes fatal epidemics in humans. This is one of the most threatening vector-borne pathogens, widely distributed, including on the European continent. Currently, there are no preventive or effective therapeutic measures available against CCHFV, which is listed as a key priority in the WHO’s R&D Blueprint list of infectious agents with epidemic or pandemic potential.

Deep structural biology studies on viral glycoproteins and investigation of the immunogenicity of the viral antigens will be combined with optimisation of a mRNA vaccine candidate against the virus and characterisation of the resulting protective immunity, as well as with the development of immuno-therapeutic monoclonal antibodies (mAbs) based on CCHFV’s antigenic targets.


Numbers

0

partners

0

countries

0

years EU-funded

project

0M

€

News

  • CCHFVACIM’s third annual meeting: connecting research efforts against Crimean-Congo haemorrhagic fever

    On 8 October 2026, the CCHFVACIM consortium gathered at the Makedonia Hotel in Thessaloniki, Greece, for its third annual meeting. With remote participation also available, the meeting brought partners together to review progress across the project, discuss scientific challenges and consider priorities for the coming months. The programme covered the complementary research approaches underpinning CCHFVACIM’s…

  • News from the CCHFVACIM project !

    Watch our second video.

  • New Publication

    New CCHFVACIM-supported study sheds light on CCHFV infection dynamics in sheep A new study supported by the CCHFVACIM project provides detailed insights into how Crimean-Congo haemorrhagic fever virus (CCHFV) disseminates in sheep and how the animals’ immune response develops over time. Published in npj Viruses, the study was led by researchers from the Friedrich-Loeffler-Institut, with…